These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31477715)

  • 41. Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice.
    Cai WY; Lin LY; Hao H; Zhang SM; Ma F; Hong XX; Zhang H; Liu QF; Ye GD; Sun GB; Liu YJ; Li SN; Xie YY; Cai JC; Li BA
    Hepatology; 2017 Apr; 65(4):1206-1221. PubMed ID: 27809333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance.
    Szulzewsky F; Holland EC; Vasioukhin V
    Dev Biol; 2021 Jul; 475():205-221. PubMed ID: 33428889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement.
    Amelio AL; Fallahi M; Schaub FX; Zhang M; Lawani MB; Alperstein AS; Southern MR; Young BM; Wu L; Zajac-Kaye M; Kaye FJ; Cleveland JL; Conkright MD
    Proc Natl Acad Sci U S A; 2014 Aug; 111(32):E3260-8. PubMed ID: 25071166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neural Progenitor Cells Undergoing Yap/Tead-Mediated Enhanced Self-Renewal Form Heterotopias More Easily in the Diencephalon than in the Telencephalon.
    Saito K; Kawasoe R; Sasaki H; Kawaguchi A; Miyata T
    Neurochem Res; 2018 Jan; 43(1):180-189. PubMed ID: 28879493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
    Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
    Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Helicobacter pylori-induced YAP1 nuclear translocation promotes gastric carcinogenesis by enhancing IL-1β expression.
    Wu Y; Shen L; Liang X; Li S; Ma L; Zheng L; Li T; Yu H; Chan H; Chen C; Yu J; Jia J
    Cancer Med; 2019 Jul; 8(8):3965-3980. PubMed ID: 31145543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
    Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
    Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling.
    Mack SC; Pajtler KW; Chavez L; Okonechnikov K; Bertrand KC; Wang X; Erkek S; Federation A; Song A; Lee C; Wang X; McDonald L; Morrow JJ; Saiakhova A; Sin-Chan P; Wu Q; Michaelraj KA; Miller TE; Hubert CG; Ryzhova M; Garzia L; Donovan L; Dombrowski S; Factor DC; Luu B; Valentim CLL; Gimple RC; Morton A; Kim L; Prager BC; Lee JJY; Wu X; Zuccaro J; Thompson Y; Holgado BL; Reimand J; Ke SQ; Tropper A; Lai S; Vijayarajah S; Doan S; Mahadev V; Miñan AF; Gröbner SN; Lienhard M; Zapatka M; Huang Z; Aldape KD; Carcaboso AM; Houghton PJ; Keir ST; Milde T; Witt H; Li Y; Li CJ; Bian XW; Jones DTW; Scott I; Singh SK; Huang A; Dirks PB; Bouffet E; Bradner JE; Ramaswamy V; Jabado N; Rutka JT; Northcott PA; Lupien M; Lichter P; Korshunov A; Scacheri PC; Pfister SM; Kool M; Taylor MD; Rich JN
    Nature; 2018 Jan; 553(7686):101-105. PubMed ID: 29258295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. YAP1-TEAD1-Glut1 axis dictates the oncogenic phenotypes of breast cancer cells by modulating glycolysis.
    Lin C; Xu X
    Biomed Pharmacother; 2017 Nov; 95():789-794. PubMed ID: 28892790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alternative splicing reverses the cell-intrinsic and cell-extrinsic pro-oncogenic potentials of YAP1.
    Ben C; Wu X; Takahashi-Kanemitsu A; Knight CT; Hayashi T; Hatakeyama M
    J Biol Chem; 2020 Oct; 295(41):13965-13980. PubMed ID: 32763976
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    Kupp R; Ruff L; Terranova S; Nathan E; Ballereau S; Stark R; Sekhar Reddy Chilamakuri C; Hoffmann N; Wickham-Rahrmann K; Widdess M; Arabzade A; Zhao Y; Varadharajan S; Zheng T; Murugesan M; Pfister SM; Kawauchi D; Pajtler KW; Deneen B; Mack SC; Masih KE; Gryder BE; Khan J; Gilbertson RJ
    Cancer Discov; 2021 Sep; 11(9):2216-2229. PubMed ID: 33741711
    [No Abstract]   [Full Text] [Related]  

  • 52. YAP1-TEAD1 signaling controls angiogenesis and mitochondrial biogenesis through PGC1α.
    Mammoto A; Muyleart M; Kadlec A; Gutterman D; Mammoto T
    Microvasc Res; 2018 Sep; 119():73-83. PubMed ID: 29680477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP.
    Liu-Chittenden Y; Huang B; Shim JS; Chen Q; Lee SJ; Anders RA; Liu JO; Pan D
    Genes Dev; 2012 Jun; 26(12):1300-5. PubMed ID: 22677547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel YAP1 Activator, Identified by Transcription-Based Functional Screen, Limits Multiple Myeloma Growth.
    Maruyama J; Inami K; Michishita F; Jiang X; Iwasa H; Nakagawa K; Ishigami-Yuasa M; Kagechika H; Miyamura N; Hirayama J; Nishina H; Nogawa D; Yamamoto K; Hata Y
    Mol Cancer Res; 2018 Feb; 16(2):197-211. PubMed ID: 29061667
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel YAP1/SLC35B4 regulatory axis contributes to proliferation and progression of gastric carcinoma.
    Liu J; Zhao X; Wang K; Zhang X; Yu Y; Lv Y; Zhang S; Zhang L; Guo Y; Li Y; Yang A; Zhang R; Li J
    Cell Death Dis; 2019 Jun; 10(6):452. PubMed ID: 31175271
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides.
    Zhou Z; Hu T; Xu Z; Lin Z; Zhang Z; Feng T; Zhu L; Rong Y; Shen H; Luk JM; Zhang X; Qin N
    FASEB J; 2015 Feb; 29(2):724-32. PubMed ID: 25384421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ependymoma-like tumor with mesenchymal differentiation (ELTMD) with ZFTA:NCOA1 fusion: A diagnostic challenge.
    Dorwal P; White C; Goh AF; Kumar A; McEniery J; Walker R; Robertson T
    Neuropathology; 2024 Jun; 44(3):216-221. PubMed ID: 37931917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histone serotonylation regulates ependymoma tumorigenesis.
    Chen HC; He P; McDonald M; Williamson MR; Varadharajan S; Lozzi B; Woo J; Choi DJ; Sardar D; Huang-Hobbs E; Sun H; Ippagunta SM; Jain A; Rao G; Merchant TE; Ellison DW; Noebels JL; Bertrand KC; Mack SC; Deneen B
    Nature; 2024 Aug; 632(8026):903-910. PubMed ID: 39085609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors.
    Nguyen LT; Tretiakova MS; Silvis MR; Lucas J; Klezovitch O; Coleman I; Bolouri H; Kutyavin VI; Morrissey C; True LD; Nelson PS; Vasioukhin V
    Cancer Cell; 2015 Jun; 27(6):797-808. PubMed ID: 26058078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fatal correlation between YAP1 expression and glioma aggressiveness: clinical and molecular evidence.
    Guichet PO; Masliantsev K; Tachon G; Petropoulos C; Godet J; Larrieu D; Milin S; Wager M; Karayan-Tapon L
    J Pathol; 2018 Oct; 246(2):205-216. PubMed ID: 30009411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.